Argus downgraded Idex Corp. to Hold from Buy. The company is well positioned for the future, but the recent sales and order growth has slowed in two key segments – Fluid & Metering and Health and Science Technologies – due to industry slowdowns and project delays, while the stock, from a technical perspective, is now in a bearish pattern of lower highs and lower lows, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IEX:
- Idex Corp. price target lowered to $230 from $240 at TD Cowen
- Idex Corp. price target lowered to $210 from $220 at DA Davidson
- Idex Corp. price target lowered to $238 from $245 at Oppenheimer
- Idex Corp. price target lowered to $241 from $256 at Baird
- IDEX Releases Latest Quarterly Operating Results Insights